Trial Profile
A prospective, open-lable, single-arm, muti-center study evaluating the efficacy and saftety of chidamide in combination with CHOP in patients with newly diagnosed peripheral T-cell lymphoma (PTCL)
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 09 May 2017
Price :
$35
*
At a glance
- Drugs Tucidinostat (Primary) ; Cyclophosphamide; Doxorubicin; Prednisone; Vincristine
- Indications Peripheral T-cell lymphoma
- Focus Therapeutic Use
- 09 May 2017 New trial record